Abstract
Prospective cohort studies, cross-sectional surveys, autopsy studies and intervention clinical trials that investigated the association between nutrients and Alzheimer’s disease (AD) have been reviewed. To estimate the relationship between specific nutrient intake and the risk of AD, Cochrane Library, PubMed, EMBASE, and the Fisher Center for Alzheimer’s Research Foundation were searched for this purpose. Most published observational studies found an inverse relationship between vitamins, n-3 fatty acids and AD. The majority of intervention studies support the beneficial effect of combined vitamins and n-3 fatty acids providing them in the early stages of the disease. Only vitamin E and Zn supplementation failed to show any significant difference on the study population. On the other hand, high dietary intake of saturated fat and brain metal accumulation were positively associated with the incidence of AD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bowman, G.L. 2012. Ascorbic Acid, Cognitive Function, and Alzheimer’s Disease: A Current Review and Future Direction. BioFactors 38: 114–122.
Bowman, G.L., H. Dodge, B. Frei, C. Calabrese, B.S. Oken, J.A. Kaye, and J.F. Quinn. 2009. Ascorbic Acid and Rates of Cognitive Decline in Alzheimer’s Disease. Journal of Alzheimer’s Disease 16 (1): 93–98.
Farina, Nicolas, Mokhtar Gad El Kareem Nasr Isaac, Annalie R. Clark, Jennifer Rusted, and Naji Tabet. 2012. Vitamin E for Alzheimer’s Dementia and Mild Cognitive Impairment. Cochrane Database of Systematic Reviews 11: CD002854.
Zandi, P.P., J.C. Anthony, A.S. Khachaturian, S.V. Stone, D. Gustafson, J.T. Tschanz, M.C. Norton, K.A. Welsh-Bohmer, J.C. Breitner, and Cache County Study Group. 2004. Reduced Risk of Alzheimer’s Disease in Users of Antioxidant Vitamin Supplements: The Cache County Study. Archives of Neurology 61: 82–88.
Galasco, R., E. Peskind, Clark C. MD, J. Quinn, J. Ringman, Jicha G. MD, C. Cotman, B. Cottrell, T. Montine, R. Thomas, P. Aisen, and Antioxidants for Alzheimer Disease. 2012. A Randomized Clinical Trial with Cerebrospinal Fluid Biomarker Measures. Archives of Neurology 69 (7): 836–841.
Gwenaëlle, Douaud, Helga Refsum, Celeste A. de Jager, Robin Jacoby, Thomas E. Nichols, Stephen M. Smith, and A. David Smith. 2013. Preventing Alzheimer’s Disease-Related Gray Matter Atrophy by B-Vitamin Treatment. Proceedings of the National Academy of Sciences 110: 9523–9528.
Morris, M.S. 2012. The Role of B Vitamins in Preventing and Treating Cognitive Impairment and Decline. Advances in Nutrition 3: 801–812.
Smith Mark, A., Xiongwei Zhu, Massimo Tabaton, Gang Liu, Daniel W. McKeel Jr., Mark L. Cohen, Xinglong Wang, Sandra L. Siedlak, Takaaki Hayashi, Masao Nakamura, Akihiko Nunomura, and George Perry. 2010. Increased Iron and Free Radical Generation in Preclinical Alzheimer Disease and Mild Cognitive Impairment. Journal of Alzheimer’s Disease 19 (1): 363–372.
Vogel, T., N. Dali-Youcef, G. Kaltenbach, and E. Andrès. 2009. Homocysteine, Vitamin B12, Folate and Cognitive Functions: A Systematic and Critical Review of the Literature. International Journal of Clinical Practice 63: 1061–1067.
Horrocks, L.A., and A.A. Farooqui. 2004. Docosahexaenoic Acid in the Diet: Its Importance in Maintenance and Restoration of Neural Membrane Function. Prostaglandins, Leukotrienes and Essential Fatty Acids 70 (4): 361–372.
Pottala, J., K. Yaffe, J. Robinson, M. Espeland, R. Wallace, and S.W. Harris. 2014. Higher RBC EPA+DHA Corresponds with Larger Total Brain and Hippocampal Volumes. Neurology 82 (5): 435–442.
Volkert, D., M. Chourdakis, G. Faxen-Irving, T. Frühwald, F. Landi, M.H. Suominen, M. Vandewoude, R. Wirth, and S.M. Schneider. 2015. ESPEN Guidelines on Nutrition in Dementia. Clinical Nutrition 34 (6): 1052–1073.
Strike, A.C., Carlisle Alison, Gibson E. Leigh, and C. Dyall Simon. 2015. A High Omega-3 Fatty Acid Multinutrient Supplement Benefits Cognition and Mobility in Older Women: A Randomized, Double-Blind, Placebo-Controlled Pilot Study. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences: 1–9.
Shah, R.C., P.J. Kamphuis, S. Leurgans, S.H. Swinkels, C.H. Sadowsky, A. Bongers, S.A. Rappaport, F. Joseph, J.F. Quinn, R. Wieggers, P. Scheltens, and D. Bennet. 2013. The S-Connect Study: Results from a Randomized, Controlled Trial of Souvenaid in Mild-to-Moderate Alzheimer’s Disease. Alzheimer’s Research & Therapy 5: 59.
Fernandes de Abreu, D.A., D. Eyles, and F. Féron. 2009. Vitamin D, a Neuro-Immunomodulator: Implications for Neurodegenerative and Autoimmune Diseases. Psychoneuroendocrinology 34 (Suppl. 1): S265–S277.
Annweiler, C., Y. Rolland, A.M. Schott, H. Blain, B. Vellas, F.R. Herrmann, and O. Beauchet. 2012. Higher Vitamin D Dietary Intake is Associated with Lower Risk of Alzheimer’s Disease: A 7-Year Follow-Up. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 67 (11): 1205–1211.
Maylor, E.A., E.E.A. Simpson, D.L. Secker, N. Meunier, M. Andriollo-Sanchez, A. Polito, B. Stewart-Knox, C. McConville, J.M. O’Connor, and C. Coudray. 2006. Effects of Zinc Supplementation on Cognitive Function in Healthy Middle-Aged and Older Adults: The ΖENITH Study. British Journal of Nutrition 96 (4): 752–760.
Choi, D.-Y., Y.-J. Lee, J.T. Hong, and H.-J. Lee. 2012. Antioxidant Properties of Natural Polyphenols and Their Therapeutic Potentials for Alzheimer’s Disease. Brain Research Bulletin 87: 144–153.
Smith, A.D., S.M. Smith, C.A. de Jager, P. Whitbread, C. Johnston, G. Agacinski, A. Oulhaj, K.M. Bradley, R. Jacoby, and H. Refsum. 2010. Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial. PLoS One 5: e12244.
Lavados, M., M. Guillón, M.C. Mujica, L.E. Rojo, P. Fuentes, and R.B. Maccioni. 2008. Mild Cognitive Impairment and Alzheimer Patients Display Different Levels of Redox-Active CSF Iron. Journal of Alzheimer’s Disease 13 (2): 225–232.
Tofaris, G.K., T. Revesz, T.S. Jacques, S. Papacostas, and J. Chataway. 2007. Adult-Onset Neurodegeneration with Brain Iron Accumulation and Cortical Alpha-Synuclein and tau Pathology: A Distinct Clinicopathological Entity. Archives of Neurology 64: 280–282.
Yamamoto, A., et al. 2002. Iron (III) Induces Aggregation of Hyperphosphorylated tau and Its Reduction to Iron (II) Reverses the Aggregation: Implications in the Formation of Neurofibrillary Tangles of Alzheimer’s Disease. Journal of Neurochemistry 82: 1137–1147.
Squitti, R., et al. 2014. Meta-Analysis of Serum Non-ceruloplasmin Copper in Alzheimer’s Disease. Journal of Alzheimer’s Disease 38 (4): 809–822.
Squitti, R., M. Siotto, and R. Polimanti. 2014. Low-Copper Diet as Preventive Strategy to Decrease the Risk for Copper Phenotype in Alzheimer’s Disease. Neurobiology of Aging 35 (Suppl. 2): S40–S50.
Thomas, J., C.J. Thomas, J. Radcliffe, and C. Itsiopoulos. 2015. Omega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer’s Disease. BioMed Research International. Volume, Article ID 172801, 13 pp.
Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. 2001. (US) Panel on Micronutrients. Washington: National Academies Press.
Annweiler, C., B. Fantino, D. Le Gall, A.M. Schott, G. Berrut, and O. Beauchet. 2011. Severe Vitamin D Deficiency is Associated with Advanced-Stage Dementia in Geriatric Inpatients. Journal of the American Geriatrics Society 59 (1): 169–171.
Annweiler, C., D.J. Llewellyn, and O. Beauchet. 2013. Low Serum Vitamin D Concentrations in Alzheimer’s Disease: A Systematic Review and Meta-Analysis. Journal of Alzheimer’s Disease 33 (3): 659–674.
Barnard Neal, D., E. Bunner Anne, and Agarwal Ulka. 2014. Saturated and Trans Fats and Dementia: A Systematic Review. Neurobiology of Aging 35 (2): S65–S73.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this paper
Cite this paper
Kalli, E.G. (2017). Association of Nutrients with Biomarkers of Alzheimer’s Disease. In: Vlamos, P. (eds) GeNeDis 2016. Advances in Experimental Medicine and Biology, vol 987. Springer, Cham. https://doi.org/10.1007/978-3-319-57379-3_23
Download citation
DOI: https://doi.org/10.1007/978-3-319-57379-3_23
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-57378-6
Online ISBN: 978-3-319-57379-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)